首页> 外文期刊>World Journal of Gastroenterology >Indian patients with nonalcoholic fatty liver disease presenting with raised transaminases are different at presentation
【24h】

Indian patients with nonalcoholic fatty liver disease presenting with raised transaminases are different at presentation

机译:印度非酒精性脂肪肝患者转氨酶升高

获取原文
获取原文并翻译 | 示例
       

摘要

We read with great interest the article, "Non-alcoholic fatty liver disease may not be a severe disease at presentation among Asian Indians" by Madan et al in the recent issue of WJG. Twenty-eight (55%) out of 51 patients with nonalcoholic fatty liver disease (NAFLD) who presented with abnormal transaminases had histological evidence of nonalcoholic steatohepatitis (NASH). The majority of patients had grade 1 [32 (63%)] or grade 2 [16 (31%)] inflammation and either had no [23 (45%)] fibrosis or stage I [19 (37%)] fibrosis. None of the patients had cirrhosis. We agree with Madan et al that Asian Indians with NAFLD who present with unexplained increase in transaminases may have mild disease at presentation on the basis of similar observations made by us.
机译:我们非常感兴趣地阅读了Madan等人在最近一期的《 WJG》上发表的文章“非酒精性脂肪肝病可能不是亚洲印第安人中出现的严重疾病”。在51名非酒精性脂肪肝疾病(NAFLD)患者中,有28名(55%)出现转氨酶异常,其组织学证据为非酒精性脂肪性肝炎(NASH)。大多数患者患有1级[32(63%)]或2级[16(31%)]炎症,并且没有[23(45%)]纤维化或I期[19(37%)]纤维化。没有患者有肝硬化。我们同意Madan等的观点,根据我们所做的类似观察,患有NAFLD的亚洲印第安人的转氨酶水平出现无法解释的增加,在出现时可能患有轻度疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号